title: Is ZAP-70 expression stable over time in B chronic lymphocytic leukaemia?
authors.forename: Stéphanie
authors.initials: S
authors.lastname: Poulain
authors.forename: Caroline
authors.initials: C
authors.lastname: Benard
authors.forename: Agnès
authors.initials: A
authors.lastname: Daudignon
authors.forename: F
authors.initials: F
authors.lastname: Le Baron
authors.forename: Pierre
authors.initials: P
authors.lastname: Morel
authors.forename: Patrick
authors.initials: P
authors.lastname: Duthilleul
mesh_terms: D000368:Aged; D014408:Biomarkers, Tumor / Q000235:genetics; D018450:Disease Progression; D005260:Female; D005500:Follow-Up Studies; D015973:Gene Expression Regulation, Leukemic; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000235:genetics* / Q000473:pathology; D008297:Male; D051746:ZAP-70 Protein-Tyrosine Kinase / Q000235:genetics*
chemical_list: D014408:Biomarkers, Tumor; D051746:ZAP-70 Protein-Tyrosine Kinase; C497261:ZAP70 protein, human